Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)
Clinical trial NCT05002777 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05002777
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2024-05-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.